NA Ophthalmology Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	296 Pages	Data Bridge Market Research	December, 2022	DAABD17635894

Best Price Guarantee
Price	from $3,500
Length	296 Pages
Publisher	Data Bridge Market Research
Published Date	December, 2022
SKU	DAABD17635894

NA Ophthalmology Market - Industry Trends and Forecast to 2030

The North America Ophthalmology market is projected to register a substantial CAGR of 6.8 % in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentations

North America Ophthalmology Market, By Product Type (Device, Drugs, and Others), Diseases (Glaucoma, Cataract, Age-Related Macular Degeneration, Inflammatory Diseases, Refractive Disorders, and Others), Prescription Mode (Generic, and Branded), Drug Type (Prescription, and Over the Counter (OTC)), Route of Administration (Oral, Topical, Injectables, Local Ocular, and Others), End User (Hospitals, Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, and Mexico), Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the North America Ophthalmology market are:
• Rising prevalence of ophthalmic disorders & ocular pains
• Increasing unhygienic & sedentary lifestyle
• The rise in traumatic injuries
• The rise in the geriatric population

Market Players

Some of the key market players for the North America Ophthalmology market are listed below:
• Johnson & Johnson Services, Inc.
• Novartis AG
• Bausch & Lomb Incorporated
• AbbVie Inc.
• Alcon
• Santen Pharmaceutical Co., Ltd.
• Others

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The North America Ophthalmology Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 North America Ophthalmology Market: Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Product Segment Lifeline Curve; 2.8 Dbmr Market Position Grid; 2.9 Vendor Share Analysis; 2.10 Market End User Coverage Grid; 2.11 Secondary Sources
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter’s Five Forces
5 Epidemiology
6 Strategic Initiatives
7 North America Ophthalmology Market, Regulation
8 Market Overview: 8.1 Drivers; 8.1.1 Rising Prevalence Of Ophthalmic Disorders & Ocular Pains; 8.1.2 Increasing Unhygienic & Sedentary Lifestyle; 8.1.3 Rise In Traumatic Injuries; 8.1.4 Rise In The Geriatric Population; 8.2 Restraints; 8.2.1 High Cost & Risks Associated With Eye Surgery & Treatment; 8.2.2 Lack Of Health Insurance Amongst The Population, Especially Within The Developing Countries; 8.2.3 Side Effects Associated With Treatment Drugs; 8.3 Opportunities; 8.3.1 Rise In Healthcare Expenditure And Disposable Income; 8.3.2 Strategic Initiatives By Key Market Players; 8.3.3 Rising Awareness To Prevent The Burden Of Eye Diseases; 8.4 Challenge; 8.4.1 Lack Of Skilled Professionals; 8.4.2 Stringent Rules & Regulations For Product Approval
9 North America Ophthalmology Market, By Products: 9.1 Overview; 9.2 Device; 9.2.1 Surgical Device; 9.2.1.1 Cataract Surgical Devices; 9.2.1.2 Ophthalmic Viscoelastic Devices; 9.2.1.2.1 Phacoemulsification Devices; 9.2.1.2.2 Cataract Surgical Lasers; 9.2.1.2.3 Iol Injectors; 9.2.1.3 Vitreoretinal Surgical Devices; 9.2.1.3.1 Vitreoretinal Packs; 9.2.1.3.2 Vitrectomy Machines; 9.2.1.3.3 Vitrectomy Probes; 9.2.1.3.4 Photocoagulation Lasers; 9.2.1.3.5 Illumination Devices; 9.2.1.4 Refractive Surgical Devices; 9.2.1.4.1 Femtosecond Lasers; 9.2.1.4.2 Excimer Lasers; 9.2.1.4.3 Other Refractive Surgical Lasers; 9.2.1.5 Glaucoma Surgical Devices; 9.2.1.5.1 Glaucoma Drainage Devices; 9.2.1.5.2 Glaucoma Laser Systems; 9.2.1.5.3 Micro Invasive Glaucoma Surgery Devices; 9.2.2 Diagnostic Device; 9.2.2.1 Autorefractors & Keratometers; 9.2.2.2 Tonometer; 9.2.2.3 Phoropters; 9.2.2.4 Retinoscopes; 9.2.2.5 Ophthalmoscopes; 9.2.2.6 Perimeters/Visual Field Analyzers; 9.2.2.7 Ophthalmic Ultrasound Imaging Systems; 9.2.2.7.1 A- Scan Imaging System; 9.2.2.7.2 B-scan Imaging System; 9.2.2.7.3 Pachymeters; 9.2.2.7.4 Ultrasound Biomicroscopes; 9.2.2.8 Lensmeters; 9.2.2.9 Corneal Topography Systems; 9.2.2.10 Optical Coherence Tomography Scanners; 9.2.2.11 Fundus Cameras; 9.2.2.12 Optical Biometry Systems; 9.2.2.13 Specular Microscopes; 9.2.2.14 Wavefront Aberrometers; 9.2.2.15 Chart Projectors; 9.2.2.16 Slit Lamps; 9.2.3 Ophthalmic Surgical Accessories; 9.2.3.1 Surgical Instruments & Kits; 9.2.3.2 Ophthalmic Forceps; 9.2.3.3 Ophthalmic Spatula; 9.2.3.4 Ophthalmic Tips And Handles; 9.2.3.5 Ophthalmic Cannulas; 9.2.3.6 Ophthalmic Scissors; 9.2.3.7 Others Surgical Accessories; 9.2.4 Ophthalmic Microscopes; 9.3 Drugs; 9.3.1 Anti-inflammation Drugs; 9.3.1.1 Non-steroidal Anti-inflammatory Drugs; 9.3.1.2 Steroidal Anti-inflammatory Drugs; 9.3.2 Allergic Conjunctivitis; 9.3.3 Dry Eye Drugs; 9.3.4 Retinal Disorder Drugs; 9.3.5 Anti-glaucoma Drugs; 9.3.5.1 Miotics; 9.3.5.1.1 Pilocarpine; 9.3.5.1.2 Eserine; 9.3.5.2 Beta Adrenergic Antagonists; 9.3.5.2.1 Timolal Maleate; 9.3.5.2.2 Betaxolol; 9.3.5.3 Prostaglandin Analogs; 9.3.5.3.1 Latanoprost; 9.3.5.3.2 Bimatoprost; 9.3.5.3.3 Travoprost; 9.3.5.3.4 Tafluprost; 9.3.5.3.5 Latanoprostene; 9.3.5.4 Alpha Adrenergic Agonists; 9.3.5.4.1 Epinephrine; 9.3.5.4.2 Depiveprine; 9.3.5.5 Anti-vegf Drugs; 9.3.5.5.1 Ranibizumab; 9.3.5.5.2 Bevacizumab; 9.3.6 Others; 9.4 Others; 9.4.1 Vision Care Products; 9.4.1.1 Spectacles; 9.4.1.2 Contact Lenses; 9.4.1.2.1 Soft Contact Lenses; 9.4.1.2.2 Hybrid Contact Lenses; 9.4.1.2.3 Rigid Gas Permeable Lenses; 9.4.2 Others
10 North America Ophthalmology Market, By Diseases: 10.1 Overview; 10.2 Inflammatory Diseases; 10.3 Cataract; 10.4 Refractive Disorders; 10.5 Glaucoma; 10.6 Age-related Macular Degeneration; 10.7 Others
11 North America Ophthalmology Market, By Prescription Mode: 11.1 Overview; 11.2 Branded; 11.3 Generic
12 North America Ophthalmology Market, By Drug Type: 12.1 Overview; 12.2 Over The Counter; 12.3 Prescription
13 North America Ophthalmology Market, By Route Of Administration: 13.1 Overview; 13.2 Topical; 13.2.1 Eye Drops; 13.2.2 Eye Solution; 13.2.3 Cream & Ointments; 13.2.4 Gel; 13.2.5 Others; 13.3 Oral; 13.3.1 Tablet; 13.3.2 Capsules; 13.3.3 Others; 13.4 Local Ocular; 13.4.1 Subconjunctival; 13.4.2 Intravitreal; 13.4.3 Retrobulbar; 13.4.4 Intracameral; 13.5 Injectable; 13.5.1 Intramuscular; 13.5.2 Intravenous; 13.5.3 Others; 13.6 Others
14 North America Ophthalmology Market, By End User: 14.1 Overview; 14.2 Clinics; 14.3 Hospitals; 14.4 Homecare Settings; 14.5 Others
15 North America Ophthalmology Market, By Distribution Channel: 15.1 Overview; 15.2 Retail Sales; 15.2.1 Retail Shops; 15.2.2 Hospital Pharmacy; 15.2.3 Online Pharmacy; 15.3 Direct Tender; 15.4 Others
16 North America Ophthalmology Market, By Geography: 16.1 North America; 16.1.1 U.S.; 16.1.2 Canada; 16.1.3 Mexico
17 North America Ophthalmology Market: Company Landscape: 17.1 Company Share Analysis: North America
18 Swot Analysis
19 Company Profile: 19.1 Alcon; 19.1.1 Company Snapshot; 19.1.2 Recent Financials; 19.1.3 Company Share Analysis; 19.1.4 Product Portfolio; 19.1.5 Recent Developments; 19.2 Regeneron Pharmaceuticals Inc.; 19.2.1 Company Snapshot; 19.2.2 Recent Financials; 19.2.3 Company Share Analysis; 19.2.4 Product Portfolio; 19.2.5 Recent Development; 19.3 Johnson & Johnson Services, Inc.; 19.3.1 Company Snapshot; 19.3.2 Recent Financials; 19.3.3 Company Share Analysis; 19.3.4 Product Portfolio; 19.3.5 Recent Development; 19.4 Reichert, Inc.; 19.4.1 Company Snapshot; 19.4.2 Company Share Analysis; 19.4.3 Product Portfolio; 19.4.4 Recent Development; 19.5 Novartis Ag; 19.5.1 Company Snapshot; 19.5.2 Revenue Analysis; 19.5.3 Company Share Analysis; 19.5.4 Product Portfolio; 19.5.5 Recent Developments; 19.6 Abbvie Inc.; 19.6.1 Company Snapshot; 19.6.2 Recent Financials; 19.6.3 Product Portfolio; 19.6.4 Recent Development; 19.7 Bausch & Lomb Incorporated; 19.7.1 Company Snapshot; 19.7.2 Revenue Analysis; 19.7.3 Product Portfolio; 19.7.4 Recent Developments; 19.8 Carl Zeiss Meditec Ag; 19.8.1 Company Snapshot; 19.8.2 Revenue Analysis; 19.8.3 Product Portfolio; 19.8.4 Recent Developments; 19.9 Essilorluxottica; 19.9.1 Company Snapshot; 19.9.2 Revenue Analysis; 19.9.3 Product Portfolio; 19.9.4 Recent Developmen; 19.10 F. Hoffmann- La Roche Ltd; 19.10.1 Company Snapshot; 19.10.2 Revenue Analysis; 19.10.3 Product Portfolio; 19.10.4 Recent Development; 19.11 Glaukos; 19.11.1 Company Snapshot; 19.11.2 Revenue Analysis; 19.11.3 Product Portfolio; 19.11.4 Recent Developments
List Of Tables: Table 1 North America Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 2 North America Device In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 3 North America Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 4 North America Surgical Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 5 North America Ophthalmic Viscoelastic Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 6 North America Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 7 North America Refractive Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 8 North America Glaucoma Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 9 North America Diagnostic Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 10 North America Ophthalmic Ultrasound Imaging Systems In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 11 North America Ophthalmic Surgical Accessories In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 12 North America Drugs In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 13 North America Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 14 North America Anti Inflammation Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 15 North America Anti Glaucoma Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 16 North America Miotics In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 17 North America Beta Adrenergic Antagonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 18 North America Prostaglandin Analogs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 19 North America Alpha Adrenergic Agonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 20 North America Anti-vegf Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 21 North America Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 22 North America Others In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 23 North America Vision Care Products In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 24 North America Contact Lenses In Ophthalmology Market, By Products, 2021-2030 (Usd Million)); Table 25 North America Ophthalmology Market, By Diseases 2021-2030 (Usd Million); Table 26 North America Inflammatory Diseases In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 27 North America Cataract In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 28 North America Refractive Disorders In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 29 North America Glaucoma In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 30 North America Age-related Macular Degeneration In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 31 North America Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 32 North America Ophthalmology Market, By Prescription Mode, 2021-2030 (Usd Million); Table 33 North America Branded In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 34 North America Generic In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 35 North America Ophthalmology Market, By Drug Type 2021-2030 (Usd Million); Table 36 North America Over The Counter In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 37 North America Prescription In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 38 North America Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 39 North America Topical In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 40 North America Topical In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 41 North America Oral In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 42 North America Oral In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 43 North America Local Ocular In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 44 North America Local Ocular In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 45 North America Injectables In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 46 North America Injectables In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 47 North America Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 48 North America Ophthalmology Market, By End User, 2021-2030 (Usd Million); Table 49 North America Clinics In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 50 North America Hospitals In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 51 North America Home Healthcare In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 52 North America Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 53 North America Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million); Table 54 North America Retail Sales In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 55 North America Retail Sales In Ophthalmology Market, By Distribution Channel 2021-2030 (Usd Million); Table 56 North America Direct Tender In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 57 North America Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million); Table 58 North America Ophthalmology Market, By Country, 2021-2030 (Usd Million); Table 59 North America Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 60 North America Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 61 North America Surgical Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 62 North America Ophthalmic Viscoelastic Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 63 North America Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 64 North America Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 65 North America Glaucoma Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 66 North America Diagnostic Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 67 North America Ophthalmic Ultrasound Imaging Systems In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 68 North America Ophthalmic Surgical Accessories In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 69 North America Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 70 North America Anti-inflammation Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 71 North America Anti-glaucoma Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 72 North America Miotics In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 73 North America Beta Adrenergic Antagonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 74 North America Prostaglandin Analogs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 75 North America Alpha Adrenergic Agonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 76 North America Anti-vegf Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 77 North America Others In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 78 North America Vision Care Products In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 79 North America Contact Lenses In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 80 North America Ophthalmology Market, By Diseases, 2021-2030 (Usd Million); Table 81 North America Ophthalmology Market, By Prescription Mode, 2021-2030 (Usd Million); Table 82 North America Ophthalmology Market, By Drug Type, 2021-2030 (Usd Million); Table 83 North America Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 84 North America Topical In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 85 North America Oral In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 86 North America Local Ocular In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 87 North America Injectables In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 88 North America Ophthalmology Market, By End User, 2021-2030 (Usd Million); Table 89 North America Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million); Table 90 North America Retail Sales In Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million); Table 91 U.S. Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 92 U.S. Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 93 U.S. Surgical Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 94 U.S. Ophthalmic Viscoelastic Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 95 U.S. Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 96 U.S. Refractive Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 97 U.S. Glaucoma Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 98 U.S. Diagnostic Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 99 U.S. Ophthalmic Ultrasound Imaging Systems In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 100 U.S. Ophthalmic Surgical Accessories In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 101 U.S. Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 102 U.S. Anti-inflammation Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 103 U.S. Anti-glaucoma Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 104 U.S. Miotics In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 105 U.S. Beta Adrenergic Antagonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 106 U.S. Prostaglandin Analogs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 107 U.S. Alpha Adrenergic Agonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 108 U.S. Anti-vegf Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 109 U.S. Others In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 110 U.S. Vision Care Products In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 111 U.S. Contact Lenses In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 112 U.S. Ophthalmology Market, By Diseases, 2021-2030 (Usd Million); Table 113 U.S. Ophthalmology Market, By Prescription Mode, 2021-2030 (Usd Million); Table 114 U.S. Ophthalmology Market, By Drug Type, 2021-2030 (Usd Million); Table 115 U.S. Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 116 U.S. Topical In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 117 U.S. Oral In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 118 U.S. Local Ocular In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 119 U.S. Injectables In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million); Table 120 U.S. Ophthalmology Market, By End User, 2021-2030 (Usd Million); Table 121 U.S. Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million); Table 122 U.S. Retail Sales In Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million); Table 123 Canada Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 124 Canada Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 125 Canada Surgical Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 126 Canada Ophthalmic Viscoelastic Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 127 Canada Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 128 Canada Refractive Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 129 Canada Glaucoma Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 130 Canada Diagnostic Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 131 Canada Ophthalmic Ultrasound Imaging Systems In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 132 Canada Ophthalmic Surgical Accessories In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 133 Canada Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 134 Canada Anti-inflammation Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 135 Canada Anti-glaucoma Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 136 Canada Miotics In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 137 Canada Beta Adrenergic Antagonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 138 Canada Prostaglandin Analogs In Ophthalmology Market, By Products, 2021-2030 (Usd Million); Table 139 Canada Alpha Adrenergic Agonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
List Of Figures: Figure 1 North America Ophthalmology Market: Segmentation; Figure 2 North America Ophthalmology Market: Data Triangulation; Figure 3 North America Ophthalmology Market: Droc Analysis; Figure 4 North America Ophthalmology Market: North America Vs Regional Market Analysis; Figure 5 North America Ophthalmology Market: Company Research Analysis; Figure 6 North America Ophthalmology Market: Interview Demographics; Figure 7 North America Ophthalmology Market: Dbmr Position Grid; Figure 8 North America Ophthalmology Market: Vendor Share Analysis; Figure 9 North America Ophthalmology Market: End User Coverage Grid; Figure 10 North America Ophthalmology Market: Segmentation; Figure 11 Rising Prevalence Of Ophthalmic Disorders& Increasing Geriatric Population Are Expected To Drive The North America Ophthalmology Market From 2022 To 2029; Figure 12 The Device Segment Is Expected To Have The Largest Share Of The North America Ophthalmology Market From 2022 To 2029; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North America Ophthalmology Market; Figure 14 North America Ophthalmology Market: By Products, 2022; Figure 15 North America Ophthalmology Market: By Products, 2023-2030 (Usd Million); Figure 16 North America Ophthalmology Market: By Products, Cagr (2023-2030); Figure 17 North America Ophthalmology Market: By Products, Lifeline Curve; Figure 18 North America Ophthalmology Market: By Diseases, 2022; Figure 19 North America Ophthalmology Market: By Diseases, 2023-2030 (Usd Million); Figure 20 North America Ophthalmology Market: By Diseases, Cagr (2023-2030); Figure 21 North America Ophthalmology Market: By Diseases, Lifeline Curve; Figure 22 North America Ophthalmology Market: By Prescription Mode ,2022; Figure 23 North America Ophthalmology Market: By Prescription Mode, 2023-2030 (Usd Million); Figure 24 North America Ophthalmology Market: By Prescription Mode, Cagr (2023-2030); Figure 25 North America Ophthalmology Market: By Prescription Mode, Lifeline Curve; Figure 26 North America Ophthalmology Market: By Drug Type ,2022; Figure 27 North America Ophthalmology Market: By Drug Type, 2023-2030 (Usd Million); Figure 28 North America Ophthalmology Market: By Drug Type, Cagr (2023-2030); Figure 29 North America Ophthalmology Market: By Drug Type, Lifeline Curve; Figure 30 North America Ophthalmology Market: By Route Of Administration, 2022; Figure 31 North America Ophthalmology Market: By Route Of Administration, 2023-2030 (Usd Million); Figure 32 North America Ophthalmology Market: By Route Of Administration, Cagr (2023-2030); Figure 33 North America Ophthalmology Market : By Route Of Administration, Lifeline Curve; Figure 34 North America Ophthalmology Market: By End User, 2022; Figure 35 North America Ophthalmology Market: By End User, 2023-2030 (Usd Million); Figure 36 North America Ophthalmology Market: By End User, Cagr (2023-2030); Figure 37 North America Ophthalmology Market: By End User, Lifeline Curve; Figure 38 North America Ophthalmology Market: By Distribution Channel, 2022; Figure 39 North America Ophthalmology Market: By Distribution Channel, 2023-2030 (Usd Million); Figure 40 North America Ophthalmology Market: By Distribution Channel, Cagr (2023-2030); Figure 41 North America Ophthalmology Market: By Distribution Channel, Lifeline Curve; Figure 42 North America Ophthalmology Market: Snapshot (2022); Figure 43 North America Ophthalmology Market: By Country (2022); Figure 44 North America Ophthalmology Market: By Country (2023 & 2030); Figure 45 North America Ophthalmology Market: By Country (2022 & 2030); Figure 46 North America Ophthalmology Market: Products (2023-2030); Figure 47 North America Ophthalmology Market: Company Share 2022 (%) 180